propyl[(2,3,4-trimethoxyphenyl)methyl]amine, 95.0%, 10g

Methyl 5-bromo-2-(methylsulfanyl)-4-pyrimidinecarboxylate, 95.0%, 1g

tert-butyl 3-formyl-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 98%, 250mg

1-Methyl-1H-imidazole-2-carboxylic acid, 97.0%, 25g

Methyl 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2-carboxylate, 98%, 1g

5-Cyclopropaneamido-3-methylthiophene-2-carboxylic acid, 97%, 100mg

1-(2-hydroxyethyl)-3,5-dimethyl-1H-pyrazole-4-carbaldehyde, 95.0%, 250mg

(R)-(+)-2-(Methoxymethyl)-1-pyrrolidinecarboxaldehyde>98.0%(GC)1g

1-Acetyl-5-nitroindazole, 97.0%, 1g

1-Fluoro-4-isopropoxybenzene, 95.0%, 5g

Anti-GST Monoclonal Antibody1vial

Potassium [[(tert-Butoxycarbonyl)amino]methyl]trifluoroborate>97.0%(N)1g

VidofludiMus, 100mg